Researchers Advance Pulmonary Embolism Diagnosis Through Computed Tomography

Researchers at Leiden University Medical Center in The Netherlands recently published in the journal Diagnostic and Interventional Radiology a review on the value of computed tomography (CT) as a diagnostic tool for pulmonary embolism. The study is entitled “The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism.”


Acute pulmonary embolism is a life-threatening cardiovascular condition in which blood clots block one of the pulmonary arteries in the lungs, possibly leading to sudden breathing problems, rapid heart and breathing rates, cough with blood, chest pain and fainting. The prognosis of the condition mainly depends on the severity of right ventricular dysfunction and on residual pulmonary circulation.

According to the authors, the diagnosis of acute pulmonary embolism primarily relies on non-invasive imaging techniques, namely through the fast, accurate, highly specific and widely available computed tomography pulmonary angiography (CTPA). However, CTPA tends to be overused, which may result in an unnecessary risk for malignancies due to the patient exposure to X-rays. A correct implementation of clinical decision rules in the diagnosis of pulmonary embolism is needed to improve the adequate use of the technique.

The team reports that CTPA is an important resource to include or exclude a pulmonary embolism diagnosis. CT is also a prognostic tool as it evaluates the patient’s right ventricular function. In this case, a simple ratio between right ventricular and left ventricular diameter that is higher than 1.0 indicates a risk for adverse outcome, while a ratio lower than 1.0 can safely exclude adverse outcome.

Upon experiencing acute pulmonary embolism, a few patients can develop chronicthromboembolic pulmonary hypertension (CTEPH), a life-threatening condition caused by repeated or unresolved pulmonary embolism that can lead to an abnormally high blood pressure in the pulmonary arteries — pulmonary hypertension. CTEPH patients can experience shortness of breath during exercise, chest discomfort and fatigue. The condition is a major cause of severe pulmonary hypertension and right heart failure.

CTEPH can be treated through a surgical procedure called thrombectomy that allows the removal of the blood clots. According to the study, CT can also diagnose CTEPH and is becoming the imaging method of choice for CTEPH diagnosis and in the identification of patients who might benefit from thrombectomy.

The team suggests that new developments and refinement in the CT field may further increase its value as a diagnostic and prognostic tool in order to improve patient care for those with CTEPH or pulmonary embolisms.


  • CesarTex CesarTex Tuesday, 07 July 2015

    cialis levitra confronto

    cialis online pharmacy

    cheap cialis

    look here us cialis pharmacy

  • CesarTex CesarTex Tuesday, 07 July 2015

    try cialis free

    cialis buy

    buy cialis

    erfahrung mit cialis soft tabs

  • CesarTex CesarTex Tuesday, 07 July 2015

    generic version of cialis

    buy cialis

    buy cialis online

    order cialis generic

  • CesarTex CesarTex Tuesday, 07 July 2015

    cialis y levitra en venta

    cialis buy

    cialis online

    cialis prescription pills

  • YlosTex YlosTex Tuesday, 07 July 2015

    viagra duration of action - cheap viagra

    viagra coupons

    viagra super active online buy

  • YlosTex YlosTex Tuesday, 07 July 2015

    soft tabs viagra generic - cheap viagra

    buy cheap viagra

    buy viagra 24 hour shipping

  • MoisesTex MoisesTex Tuesday, 07 July 2015

    viagra without rx overnight - viagra

    buy viagra online

    viagra online sales co uk

  • Matthewjew Matthewjew Tuesday, 07 July 2015

    perbandingan cialis and levitra

    cialis without a doctor prescription

    rapaflo vs cialis

    cialis coupon

  • Feliperoowl Feliperoowl Tuesday, 07 July 2015

    levitra generico espaГ±a


    levitra spinal cord injury

    canadian levitra

  • canadian pharmacy canadian pharmacy Tuesday, 07 July 2015

Leave your comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

About Us

The Saudi Association for Pulmonary Hypertension (SAPH) is a medical and research national group of many medical specialists, who shared a common interest in the field of pulmonary vascular disease. The main goal for SAPH is to increase the awareness and the knowledge of pulmonary vascular diseases in the society and between the medical professionals.

The Saudi Association for Pulmonary Hypertension (SAPH) is a Subsidiary of The

Saudi Association for PH

STS office (Exit 11 & the Airport Road)

Riyadh, Saudi Arabia

P. O. Box 106911
Riyadh 11676
Saudi Arabia

Fax: +966-11-2487431

We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…